S. 2220 · 118th Congress · Commerce
PREVAIL Act
- IntroducedJul 10, 2023 Done
- CommitteeReported Dec 2, 2024 Done
- Senate floorDied Jan 3, 2025 Stopped here
- House floorNot yet Not reached yet
- Chambers agreeNot yet Not reached yet
- PresidentNot yet Not reached yet
What it does
The Congressional Research Service hasn’t published a summary of this bill. Read the full text on Congress.gov.Who lobbies on it
30 organizations · 133 filings · Q3 2023–Q4 2024One square per quarter since introduction, oldest left. Filled = named it that quarter.
-
Chamber of Commerce of the U.s.a.
6 of 6 quarters
“…S. 2220, Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act S. 2780, Medication Affordability and Patent Integrity Act S.5160, A bill to expand the sharing of information with respect to suspected violations of intellectual property rights in trade Potential legislation similar to…”
$74.5M lobbying spend in 2024, all issuesQ4 2024 filing
-
Pharmaceutical Research and Manufacturers of America
6 of 6 quarters
“…S. 2220: PREVAIL Act - Provisions related to the PTAB S. 2780: Medication Affordability and Patent Integrity Act S. 3583: A bill to address patent thickets. - Provisions related to patents S. 4878: REMEDY Act S. 5573: A bill to amend title 35, United States Code, to provide for a safe harbor from infringement of a…”
$31.0M lobbying spend in 2024, all issuesQ4 2024 filing
-
Amgen Inc
6 of 6 quarters
“…S.2220/HR 4370 Promoting and Respecting Economically Vital American Innovation Leadership Act S.1128: A bill to establish special rules relating to information provided with respect to drug applications concerning method of use patents H.R. 3858/S.1834: A bill to prohibit the President from negotiating or concluding…”
$11.6M lobbying spend in 2024, all issuesQ4 2024 filing
27 more organizations, every filingPROUpgrade
Organizations that named S. 2220 in a quarterly lobbying report. Covers organizations with a PAC on file; reports from organizations without one aren’t loaded yet. Spend is the organization’s total across all issues: reports don’t split spending by bill. “Gave to” means the organization’s PAC gave to the member’s campaign in the 2025–26 cycle, net of refunds; it doesn’t mean the money was about this bill. Organizations may lobby for, against, or to change a bill; filings don’t say which. Source: Senate lobbying disclosures (LD-2) from lda.gov; PAC gifts from FEC filings; quotes are word for word from the “specific lobbying issues” field; where a filing lists many bills, the quote starts where it names this one.
Actions
5 actions · newest first- Dec 2, 2024Placed on Senate Legislative Calendar under General Orders. Calendar No. 650.
- Dec 2, 2024Committee on the Judiciary. Reported by Senator Durbin with an amendment in the nature of a substitute. Without written report.
- Nov 21, 2024Committee on the Judiciary. Ordered to be reported with an amendment in the nature of a substitute favorably.
- Jul 10, 2023Read twice and referred to the Committee on the Judiciary.
Show all 5 actionsShow fewer
- Jul 10, 2023Introduced in Senate